FRAGILE-COLCOVID19: A Clinical Trial Based on Early Administration of an Oral Combination of Colchicine and Prednisone in Elderly Patients with COVID-19 in Geriatric Facilities
ConclusionsThe combination colchicine/prednisone compared with intravenous dexamethasone has shown a remarkable trend to increase disease survival over a 28-day period in elderly patients requiring oxygen therapy in geriatric centers, without safety issues.Clinical Trial RegistryClinical Trials Registration Number: NCT04492358.
Source: Clinical Drug Investigation - Category: Drugs & Pharmacology Source Type: research
More News: Clinical Trials | Colchicine | Colcrys | Coronavirus | COVID-19 | Dexamethasone | Drugs & Pharmacology | Geriatrics | Laboratory Medicine | Nurses | Nursing | Pandemics | Prednisone | Study